Fuxin Zha

Association of baseline and cumulative cholesterol–high-density lipoprotein–glucose index with cardiometabolic multimorbidity: prospective evidence from two cohort studies

It is suggested that CHG, particularly its cumulative exposure, may serve as a potential marker of CMM risk and burden, however, further prospective validation is needed before CHG can be used for clinical risk prediction or to define decision thresholds.